ArticleJournal of bone and mineral metabolism2012

The effect of risedronate (17.5 mg/week) treatment on quality of life in Japanese women with osteoporosis: a prospective observational study.

Toshitaka Nakamura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.